Research Article

Gambaran hasil pemeriksaan faal hemostasis pada penderita Diabetes Melitus tipe-2 (DM-2) di RSUP Sanglah, Bali, Indonesia

Nyoman Pramudita , Ni Kadek Mulyantari

Nyoman Pramudita
Pendidikan Dokter Umum, Fakultas Kedokteran, Universitas Udayana, Bali, Indonesia. Email: pramuditanyoman@yahoo.com

Ni Kadek Mulyantari
Departemen Patologi Klinik, Fakultas Kedokteran, Universitas Udayana, RSUP Sanglah, Bali, Indonesia
Online First: June 17, 2019 | Cite this Article
Pramudita, N., Mulyantari, N. 2019. Gambaran hasil pemeriksaan faal hemostasis pada penderita Diabetes Melitus tipe-2 (DM-2) di RSUP Sanglah, Bali, Indonesia. Intisari Sains Medis 10(2). DOI:10.15562/ism.v10i2.392


Background: Diabetes Mellitus Type II (DM-2) is a type of hyperglycemic state which is related to metabolic disorders caused by mutations in several genes. Faal hemostasis is a function of the body that aims to maintain the blood that has been thinned so that the blood flowing in the veins and could be interfere with blood glucose level. This study aims to describe the faal hemostasis examination in patients with DM-2 in Sanglah Hospital.

Methods: A cross-sectional study was conducted among patients with diabetes mellitus type II (DM-2) who were hospitalized in Sanglah hospital at the period started from January 1st to December 31st, 2015. The sample selection were using consecutive sampling with a total of twenty eight samples. Data were analyzed using SPSS version 17 for Windows

Results: The study found that males were predominant in this study (53.6%). In addition, 51-60 years age group were also predominant (39.3%), following by history of hypertension (82.1%), 10-14 seconds of Prothrombin Time (PT) (67.9%), 30-40 seconds of Activated Partial Thromboplastin Time (APTT) (53.5%), and bleeding time (BT) > 1.3 minutes (67.9%).

Conclusion: Several faal hemostasis assessments were predominant in patients with DM-2 such as 10-14 seconds of PT, 20-40 seconds of APTT, and bleeding time more than 1.3 minutes.

References

Barclay A, Gilbertson H, Marsh K, Smart C. Dietary management in diabetes. Aust Fam Physician. 2010; 39(8):579-83.

Kharroubi AT, Darwish HM. Diabetes mellitus: The epidemic of the century. World J Diabetes. 2015 Jun 25;6(6):850-67

Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine (Abingdon). 2014; 42(12): 698–702.

Mihardja L, Soetrisno U, Soegondo S. Prevalence and clinical profile of diabetes mellitus in productive aged urban Indonesians. J Diabetes Investig. 2014;5(5):507-12.

Garry-Webb TL, Suglia SF, Tehranifar P. Social Epidemiology of Diabetes and Associated Conditions. Curr Diab Rep. 2013; 13(6):850–859.

Tapp RJ, Shaw JE, Harper CA et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care. 2003 ;26(6):1731-7.

Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications. 2001 ;15(1):44-54.

Awad N, Langi YA, Pandelaki K. Gambaran faktor resiko pasien diabetes melitus tipe II di poliklinik endokrin Bagian/SMF FK-Unsrat RSU Prof. Dr. R.D Kandou Manado Periode Mei 2011 - Oktober 2011. Jurnal e-Biomedik (eBM). 2013; 1(1):45-49.

Langi YA. Penatalaksanaan ulkus kaki diabetes secara terpadu. Jurnal Biomedik. 2011; 3(2):95-101

Mayangsari E, Octaviana EW, Farihatun A. Gambaran hasil pemeriksaan bleeding time (waktu perdarahan) dengan metode IVY dan DUKE. Jurnal Stikes Muhammadiyah Ciamis. [Skripsi]. 2016: 1-24


No Supplementary Material available for this article.
Article Views      : 40
PDF Downloads : 21